Role of Circulating Fibroblast Growth Factor 21 Measurement in Primary Prevention of Coronary Heart Disease Among Chinese Patients With Type 2 Diabetes Mellitus

BACKGROUND: Fibroblast growth factor 21 (FGF21) has demonstrated beneficial effects on lipid and carbohydrate metabolism. In cross‐sectional studies, an association of raised circulating FGF21 levels with coronary heart disease (CHD) was found in some but not all studies. Here we investigated prospe...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Chi Ho, Woo, Yu Cho, Chow, Wing Sun, Cheung, Chloe Yu Yan, Fong, Carol Ho Yi, Yuen, Michele Mae Ann, Xu, Aimin, Tse, Hung Fat, Lam, Karen Siu Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5669163/
https://www.ncbi.nlm.nih.gov/pubmed/28588089
http://dx.doi.org/10.1161/JAHA.116.005344

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5669163/
https://www.ncbi.nlm.nih.gov/pubmed/28588089
http://dx.doi.org/10.1161/JAHA.116.005344

Ejemplares similares